Research

Life Sciences & Biotechnology

Title :

Identification and functional characterization of novel Hv₁ channel inhibitors for neuroprotection

Area of research :

Life Sciences & Biotechnology

Focus area :

Neurobiology, Pharmacology

Principal Investigator :

Dr. Aravind singh kshatri, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh

Timeline Start Year :

2024

Timeline End Year :

2026

Contact info :

Details

Executive Summary :

Voltage-gated proton channels (Hv₁) are found in the microglia of mammalian nervous systems and are linked to neuroinflammation. Persistent activation of these channels contributes to chronic neuroinflammation and neurodegeneration. Currently, no Hv₁ inhibitors with reasonable affinity and selectivity exist. To address this, researchers aim to identify new classes of potent and selective Hv₁ channel inhibitors using a novel fluorescent-based HTS methodology. Hit compounds will be characterized using patch clamp electrophysiology, and structure-functional studies will generate lead compounds. The binding sites of identified Hv₁ inhibitors will be deduced using molecular docking, mutagenesis experiments, and mathematical modelling. Successful completion of this work could lead to the development of Hv₁ channel inhibitors as potential therapeutics for neurodegenerative diseases like Alzheimer's and Parkinson's.

Total Budget (INR):

27,64,800

Organizations involved